Buchumschlag

Dose-intensified SBRT for vertebral oligometastases: results from a prospective clinical trial

Purpose - To prospectively evaluate safety and efficacy of dose-intensified multifraction SBRT using a simultaneous-integrated boost concept for vertebral oligometastases. - Material and Methods - Data from 128 patients with 143 vertebral oligometastases (≤5 distant metastases in total) treated with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Guckenberger, Matthias (VerfasserIn) , Wilke, Lotte (VerfasserIn) , Billiet, Charlotte (VerfasserIn) , Rogers, Susanne (VerfasserIn) , Franzese, Ciro (VerfasserIn) , Schnell, Daniel (VerfasserIn) , Spałek, Mateusz (VerfasserIn) , Aebersold, Daniel M. (VerfasserIn) , Hemmatazad, Hossein (VerfasserIn) , Zilli, Thomas (VerfasserIn) , Boda-Heggemann, Judit (VerfasserIn) , Baumert, Brigitta (VerfasserIn) , Stelmes, Jean-Jacques (VerfasserIn) , Nägler, Franziska (VerfasserIn) , Gut, Philipp (VerfasserIn) , Weiß, Christian (VerfasserIn) , Bruni, Alessio (VerfasserIn) , Zimmermann, Frank (VerfasserIn) , Förster, Robert (VerfasserIn) , Zimmer, Jörg (VerfasserIn) , Madani, Indira (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: July 2025
In: Radiotherapy and oncology
Year: 2025, Jahrgang: 208, Pages: 1-7
ISSN:1879-0887
DOI:10.1016/j.radonc.2025.110940
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1016/j.radonc.2025.110940
Verlag, kostenfrei, Volltext: https://www.sciencedirect.com/science/article/pii/S016781402500235X
Volltext
Verfasserangaben:Matthias Guckenberger, Lotte Wilke, Charlotte Billiet, Susanne Rogers, Ciro Franzese, Daniel Schnell, Mateusz Spałek, Daniel M. Aebersold, Hossein Hemmatazad, Thomas Zilli, Judit Boda-Heggemann, Brigitta G. Baumert, Jean-Jacques Stelmes, Franziska Nägler, Philipp Gut, Christian Weiß, Alessio Bruni, Frank Zimmermann, Robert Förster, Jörg Zimmer, Indira Madani
Beschreibung
Zusammenfassung:Purpose - To prospectively evaluate safety and efficacy of dose-intensified multifraction SBRT using a simultaneous-integrated boost concept for vertebral oligometastases. - Material and Methods - Data from 128 patients with 143 vertebral oligometastases (≤5 distant metastases in total) treated with dose-intensified SBRT (48.5 Gy/10 [with epidural involvement] or 40 Gy/5 [without epidural involvement]) in the randomized and non-randomized arms of a phase 3 clinical trial conducted at 18 international centers between 2016 and 2023 were analyzed. - Results - The median age of all patients was 68 years; 77 patients (60.2%) had breast and prostate cancer. Of 143 vertebral metastases, 23 (16.1%) and 22 metastases (15.4%) had epidural and paraspinal tumor involvement, respectively. The median follow-up time was 24 months. At 2 years, cumulative incidence of local failure (4 failures) was 5.3%. There were 4 (2.8%) baseline and 8 (5.6%) de novo vertebral compression fractures (VCFs). Two-year OS was 82.2% (95% CI, 74.9-89.6%). There was no grade ≥ 4 adverse events (AE) and the crude rate of grade 3 AEs was 5.5%; no myelopathy or plexopathy was observed. On multivariate analysis, only non-breast or non-prostate cancer (HR, 7.91; 95%, CI 1.79-35.03; 2-sided P = 0.01) were found to be prognostic for adverse OS. No prognostic factors for VCF were identified. Epidural and paraspinal involvement were not found to be prognostic for treatment outcome. - Conclusions - Dose-intensified SBRT for vertebral oligometastases is effective and safe, even in high-risk patients with epidural or paraspinal involvement.
Beschreibung:Online verfügbar: 14. Mai 2025, Artikelversion: 24. Mai 2025
Gesehen am 04.09.2025
Beschreibung:Online Resource
ISSN:1879-0887
DOI:10.1016/j.radonc.2025.110940

Ähnliche Einträge